Importance of human papillomavirus (HPV) screening in the follow-up after CIN2-3 treatment. A study of 386 cases;Intérêt de la recherche du papillomavirus humain (HPV) dans le suivi post-conisation des CIN2-3. À propos de 386 cas

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 37, Issue 4, 2008, Pages 329-337

  Riethmuller, D ^a   Gabelle, C ^a   Ramanah, R ^a   Sautiere J L ^a   Pretet J L ^b   Schaal, J P ^c   Kantelip, B ^b   Mougin, C ^b   Maillet, R ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cervical excision; CIN; Colposcopy; HPV

Indexed keywords

ARTICLE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PATHOLOGY; POSTOPERATIVE PERIOD; PREDICTION; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING; SENSITIVITY ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MASS SCREENING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UTERINE CERVICAL NEOPLASMS;

EID: 44349130895     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgyn.2007.12.012     Document Type: Article

References (47)

1. Soutter W.P., De Barros Lopes A., Fletcher A., Monaghan J.M., Duncan I.D., Paraskevaidis E., et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 349 (1997) 978-980
2. Baldauf J.J., Dreyfus M., Ritter J., Cuenin C., Tissier I., and Meyer P. Cytology and Colposcopy after loop electrosurgical excision: implications for follow-up. Obstet Gynecol 92 (1998) 124-130
3. Fahey M.F., Irwing L., and Macaskill P. Meta analysis of Pap test accurancy. Am J Epidemiol 141 (1995) 680-686
4. Cuzick J., Clavel C., Petry K.U., Meijer C.J., Hoyer H., Ratnam S., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 119 (2006) 1095-1101
5. Paraskevaidis E., Koliopoulos G., Alamanos Y., Malamou-Mitsi V., Lolis E.D., and Kitchener H.C. Human papillomavirus testing and the outcome of treatment for cervical intraepithelial neoplasia. Obstet Gynecol 98 (2001) 833-836
6. Agence Nationale d'Accréditation et d'Évaluation en Santé. Conduite à tenir devant un frottis anormal du col de l'utérus. Paris 1998. www.has-sante.fr.
7. Chua K.L., and Hjerpe A. Human papillomavirus analysis as a prognostic marker following conization of the cervix uteri. Gynecol Oncol 66 (1997) 108-113
8. Verguts J., Bronselaer B., Donders G., Arbyn M., Van Eldere J., Drijkoningen M., et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: The role of human papillomavirus testing and age at conisation. BJOG 113 (2006) 1303-1307
9. Bosh F.X., Manos M.M., Munoz N., Sherman M., Jansen A.M., Peto J., et al., International Biological Study on Cervival Cancer (IBSCC) Study Group. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Int 87 (1995) 796-802
10. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 (1999) 12-19
11. Paraskevaidis E., Arbyn M., Sotiriadis A., Diakomanolis E., Martin-Hirsch P., Koliopoulos G., et al. The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the litterature. Cancer Treat Rev 30 (2004) 205-211
12. Zielinski G.D., Rozendaal L., Voorhorst F.J., Berkhof J., Snijders P.J., Risse E.J., et al. HPV testing can reduce the number of follow-up visits in women treated for cervical intraepithelial neoplasia grade 3. Gynecol Oncol 91 (2003) 67-73
13. Zielinski G.D., Bais A.G., Helmerhorst T.J., Verheijen R.H., de Schipper F.A., Snijders P.J., et al. HPV testing and monitoring of women after treatment of CIN3: Review of the literature and meta-analysis. Obstet Gynecol Surv 59 (2004) 543-553
14. Nagai Y., Maehama T., Asato T., and Kanazawa K. Persistence of human papillomavirus infection after therapeutic conization for CIN3: is it an alarm for disease recurrence?. Gynecol Oncol 79 (2000) 294-299
15. Lin C.T., Tseng C.J., Lai C.H., Hsueh S., Huang K.G., Huang H.J., et al. Value of human papillomavirus deoxyribonucleic acid testing after conization in the prediction of residual disease in the subsequent hysterectomy specimen. Am J Obstet Gynecol 84 (2001) 940-945
16. Jain S., Tseng C.J., Horng S.G., Soong Y.K., and Pao C.C. Negative predictive value of human papillomavirus test following conization of the cervix uteri. Gynecol Oncol 82 (2001) 177-180
17. Elfgren K., Jacobs M., Walboomers J.M., Meijer C.J., and Dillner J. Rate of human papillomavirus clearance after treatment of cervical intraepithelial neoplasia. Obstet Gynecol 100 (2002) 965-971
18. Cruickshank M.E., Sharp L., Chambers G., Smart L., and Murray G. Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia. BJOG 109 (2002) 579-581
19. Bodner K., Bodner-Adler B., Wierrani F., Kimberger O., Denk C., and Grunberger W. Is therapeutic conization sufficient to eliminate a high-risk HPV infection of the uterine cervix? A clinicopathological analysis. Anticancer Res 22 (2002) 3733-3736
20. Bekkers R.L., Melchers W.J., Bakkers J.M., Hanselaar A.G., Quint W.G., Boonstra H., et al. The role of genotype-specific human papillomavirus detection in diagnosing residual cervical intraepithelial neoplasia. Int J Cancer 102 (2002) 148-151
21. Acladious N.N., Sutton C., Mandal D., Hopkins R., Zaklama M., and Kitchener H. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN). Int J Cancer 98 (2002) 435-439
22. Houfflin Debarge V., Collinet P., Vinatier D., Ego A., Dewilde A., Boman F., et al. Value of HPV testing after conisation by loop electrosurgical excision for HGSIL. Gynecol Oncol 90 (2003) 587-592
23. Bar-Am A., Gamzu R., Levin I., Fainaru O., Niv J., and Almog B. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up. Gynecol Oncol 91 (2003) 149-153
24. Sarian L.O., Derchain S.F., Andrade L.A., Tambascia J., Morais S.S., and Syrjanen K.J. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol 94 (2004) 181-186
25. Cecchini S., Carozzi F., Confortini M., Zappa M., and Ciatto S. Persistent human papilloma virus infection as an indicator of risk of recurrence of high-grade cervical intraepithelial neoplasia treated by the loop electrosurgical excision procedure. Tumori 90 (2004) 225-228
26. Hernadi Z., Szoke K., Sapy T., Krasznai Z.T., Soos G., Veress G., et al. Role of human papillomavirus (HPV) testing in the follow-up of patients after treatment for cervical precancerous lesions. Eur J Obstet Gynecol Reprod Biol 118 (2005) 229-234
27. Kreimer A.R., Guido R.S., Solomon D., Schiffman M., Wacholder S., Jeronimo J., et al. Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease. Cancer Epidemiol Biomarkers Prev 15 (2006) 908-914
28. Alonso I., Torne A., Puig-Tintore L.M., Esteve R., Quinto L., Campo E., et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN2-3. Gynecol Oncol 103 (2006) 631-636
29. Prétet J.L., Dalstein V., Monnier-Benoit S., Delpeut S., and Mougin C. High risk HPV load estimated by Hybrid Capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV16-infected women. J Clin Virol 31 (2004) 140-147
30. Murdoch J.B., Morgan P.R., Lopes A., and Monaghan J.M. Histological incomplete excision of CINafter large loop excision of the transformation zone (LLETZ) merits careful follow up, no retreatment. Br J Obstet Gynaecol 99 (1992) 930-933
31. Bigrigg A., Haffenden D.K., Sheehan A.L., Codling B.W., and Read M.D. Efficacy and safety of large-loop excision of the transformation zone. Lancet 343 (1994) 32-34
32. Ronco G., Segnan N., Giorgi-Rossi P., Zappa M., Casadei G.P., Carozzi F., et al., New Technologies for Cervical Cancer Working Group. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 98 (2006) 765-774
33. Reich O., Pickel H., Lahousen M., Tamussino K., and Winter R. Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins. Obstet Gynecol 97 (2001) 428-430
34. Reich O., Lahousen M., Pickel H., Tamussino K., and Winter R. Cervical intraepithelial neoplasia III: long-term follow-up after cold-knife conization with involved margins. Obstet Gynecol 99 (2002) 193-196
35. Murta E.F., Resende A.V., Souza M.A., Adad S.J., and Salum R. Importance of surgical margins in conization for CIN III. Arch Gynecol Obstet 263 (1999) 42-44
36. Huang M., and Anderson P. Positive margins after cervical conization as an indicator of residual dysplasia. Prim Care Update Ob Gyn 5 (1998) 160-161
37. Bretelle F., Clavello L., Yang L., Benmoura D., Roger V., and Blanc B. Conisation non in sano : quelle attitude adopter ?. Ann Chir 125 (2000) 444-449
38. Sarian L.O., Derchain S.F., Pitta Dda R., Morais S.S., and Rabelo-Santos S.H. Factors associated with HPV persistence after treatment for high-grade cervical intraepithelial neoplasia with large loop excision of the transformation zone (LLETZ). J Clin Virol 31 (2004) 270-274
39. Ho G.Y., Burk R.D., Lkein S., Kadish A.S., Chang C.J., Palan P., et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87 (1995) 1365-1371
40. Remmink A.J., Walboomers J.M., Helmerhost T.J., Voorhost F.J., Rozendaal L., Risse E.K., et al. The presence of persistent high-risk HPV genotype in dysplasic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61 (1995) 306-311
41. Nobbenhuis M.A., Walboomers J.M., Helmerhost T.J., Rozendaal L., Remmink A.J., Risse E.K., et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354 (1999) 20-25
42. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92 (2000) 690-698
43. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M., et al. Hydrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 80 (1999) 1306-1311
44. Syrjanen S., Shabalova I.P., Petrovichev N., Kozachenko V.P., Zakharova T., Pajanidi A., et al. Clearance of high-risk HPV DNA and PAP smear abnormalities in a cohort of women subjected to HPV screening in the New Independent States of the former Soviet Union (the NIS cohort study). Eur J Obstet Gynecol Reprod Biol 19 (2005) 219-227
45. Elfgren K., Bistoletti P., Dillner L., Walboomers J.M., Meijer C.J., and Dillner J. Conization for cervical intraepithelial neoplasia is followed by disappearance of human papillomavirus deoxyribonucleic acid and a decline in serum and cervical mucus antibodies against HPV antigens. Am J Obstet Gynecol 174 (1996) 937-942
46. Nobbenhuis M.A., Meijer C.J., van den Brule A.J., Rozendaal L., Voorhorst F.J., Risse E.K., et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84 (2001) 796-801
47. Kyrgiou M., Koliopoulos G., Martin-Hirsch P., Arbyn M., Prendiville W., and Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 367 (2006) 489-498